Home / Business and Economy / P&G Health Profit Surges 54.6% in March Quarter
P&G Health Profit Surges 54.6% in March Quarter
26 May
Summary
- Net profit soared 54.6% to ₹94.6 crore in the March quarter.
- Revenue grew 19.1% to ₹371 crore, with EBITDA margins expanding.
- Company recommended a final dividend of ₹45 per equity share for FY26.
Procter & Gamble Health Ltd. announced a substantial increase in its March quarter earnings for FY26. The company's net profit climbed 54.6% to ₹94.6 crore compared to the same period last year. Revenue from operations also saw a healthy rise of 19.1%, reaching ₹371 crore.
Earnings before interest, tax, depreciation, and amortisation (EBITDA) demonstrated strong growth, increasing by 67.6% to ₹135.6 crore. This led to a significant expansion in the EBITDA margin, which improved to 37% from 26%. For the full fiscal year 2026, P&G Health reported revenue of ₹1,408 crore and an annual net profit of ₹326.9 crore.
The board has recommended a final dividend of ₹45 per equity share for FY26. Coupled with previously declared dividends, the total payout for the fiscal year amounts to ₹205 per share. The company anticipates no material financial impact from the upcoming implementation of new labor codes in November 2025.
